Literature DB >> 26886020

Advances in the management of severe aortic stenosis.

K E O'Sullivan1, S Bargenda2, D Sugrue3, J Hurley2.   

Abstract

BACKGROUND: Recent developments in the management of severe aortic stenosis have resulted in a paradigm shift in the way we view the condition. Patients previously denied intervention in the form of surgical aortic valve replacement (SAVR) are now candidates for transcatheter aortic valve implantation and the risk and age profiles of those undergoing SAVR are rising with the ageing population. This review article is designed to provide an overview of developments in the surgical management of severe aortic stenosis. We also discuss the expanding role of minimally invasive surgical approaches to outline the current techniques available to treat patients with severe aortic stenosis.
METHODS: PubMed was searched using the terms 'severe aortic stenosis', 'surgical aortic valve replacement', 'transcatheter aortic valve replacement', 'mechanical aortic valve replacement' and 'sutureless aortic valve replacement'. Selection of articles was based on peer review, journal and relevance. Where possible articles from high-impact factor peer review journals were included.
RESULTS: Minimally invasive operative approaches include mini-sternotomy and mini-thoracotomy. Sutureless aortic prostheses reduce aortic cross-clamp time and cardiopulmonary bypass time; however, long-term follow-up data are unavailable at this time. Mechanical prostheses are advised for those under 60.
CONCLUSION: Multiple advances in the surgical management of aortic stenosis have occured in the past decade. An evolving spectrum of surgical and transcatheter interventions is now available depending on patient age and operative risk.

Entities:  

Keywords:  Aortic stenosis; Mechanical; Tissue; Valve replacement

Mesh:

Year:  2016        PMID: 26886020     DOI: 10.1007/s11845-016-1417-7

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  65 in total

1.  Delayed dislocation of a sutureless aortic bioprosthesis: the first case.

Authors:  Giovanni Concistrè; Antonio Miceli; Francesca Chiaramonti; Mattia Glauber
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-03-02

Review 2.  Results with mechanical cardiac valvular prostheses.

Authors:  C W Akins
Journal:  Ann Thorac Surg       Date:  1995-12       Impact factor: 4.330

3.  Minimal access aortic valve replacement: effects on morbidity and resource utilization.

Authors:  Nicolas Doll; Michael A Borger; Joerg Hain; Jan Bucerius; Thomas Walther; Jan F Gummert; Friedrich W Mohr
Journal:  Ann Thorac Surg       Date:  2002-10       Impact factor: 4.330

4.  The Italian study on the Mitroflow postoperative results (ISTHMUS): a 20-year, multicentre evaluation of Mitroflow pericardial bioprosthesis.

Authors: 
Journal:  Eur J Cardiothorac Surg       Date:  2010-07-10       Impact factor: 4.191

5.  Ministernotomy versus median sternotomy for aortic valve replacement: a prospective, randomized study.

Authors:  A Aris; M L Cámara; J Montiel; L J Delgado; J Galán; H Litvan
Journal:  Ann Thorac Surg       Date:  1999-06       Impact factor: 4.330

6.  Transapical transcatheter aortic valve implantation without prior balloon aortic valvuloplasty: feasible and safe.

Authors:  Lenard Conradi; Moritz Seiffert; Johannes Schirmer; Dietmar Koschyk; Stefan Blankenberg; Hermann Reichenspurner; Patrick Diemert; Hendrik Treede
Journal:  Eur J Cardiothorac Surg       Date:  2013-12-11       Impact factor: 4.191

7.  Ten-year comparison of pericardial tissue valves versus mechanical prostheses for aortic valve replacement in patients younger than 60 years of age.

Authors:  Alberto Weber; Hassan Noureddine; Lars Englberger; Florian Dick; Brigitta Gahl; Thierry Aymard; Martin Czerny; Hendrik Tevaearai; Mario Stalder; Thierry Pierre Carrel
Journal:  J Thorac Cardiovasc Surg       Date:  2012-02-17       Impact factor: 5.209

Review 8.  Development of transcatheter aortic valve implantation (TAVI): a 20-year odyssey.

Authors:  Alain Cribier
Journal:  Arch Cardiovasc Dis       Date:  2012-03-16       Impact factor: 2.340

9.  Reduced anticoagulation after mechanical aortic valve replacement: interim results from the prospective randomized on-X valve anticoagulation clinical trial randomized Food and Drug Administration investigational device exemption trial.

Authors:  John Puskas; Marc Gerdisch; Dennis Nichols; Reed Quinn; Charles Anderson; Birger Rhenman; Lilibeth Fermin; Michael McGrath; Bobby Kong; Chad Hughes; Gulshan Sethi; Michael Wait; Tomas Martin; Allen Graeve
Journal:  J Thorac Cardiovasc Surg       Date:  2014-01-12       Impact factor: 5.209

10.  Carpentier-Edwards Perimount Magna valve versus Medtronic Hancock II: a matched hemodynamic comparison.

Authors:  Michael A Borger; A Franka Nette; Manjula Maganti; Christopher M Feindel
Journal:  Ann Thorac Surg       Date:  2007-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.